SavedAdd your journal

Journals / Journal of Surgery and Medicine / 2026 / Cilt: 5 Sayı: 9

The effect of cardiac rehabilitation on anxiety and depression in percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) patients

Perkütan Koroner Girişim (PCI) ve Koroner Arter Bypass Greftleme (CABG) Hastalarında Kardiyak Rehabilitasyonun Anksiyete ve Depresyon Üzerine Etkisi

Pınar Demir Gündoğmuş(Department of Cardiology, TC. Ministry of Health, Kırıkkale Yüksek İhtisas Hospital, Kırıkkale, Turkey)0000-0001-8042-189X
İbrahim Gündoğmuş(Department of Psychiatry, TC. Ministry of Health, Kırıkkale Yüksek İhtisas Hospital, Kırıkkale, Turkey)0000-0002-1921-1495
Pages
867–870
Publication Date
2021-09-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prospective and controlled studies with larger sample sizes are needed to support our findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aim: It is well-known that Cardiac Rehabilitation (CR) brings about a marked improvement in depression and anxiety.
📊
Key Findings & Data:Methods: This cross-sectional study included 27 patients with PCI and 16 patients who had undergone CABG admitted to the CR program.
💡
Conclusion & Impact:Prospective and controlled studies with larger sample sizes are needed to support our findings.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Anksiyete · depresyon · kardiyak rehabilitasyon

Abstract

Background/Aim: It is well-known that Cardiac Rehabilitation (CR) brings about a marked improvement in depression and anxiety. As far as we know, there are no studies that research the effect of CR, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Grafting (CABG) on anxiety and depression. This study aimed to investigate the effects of the CR program on anxiety and depression and the change of anxiety and depression symptoms in patients who underwent PCI and CABG. Methods: This cross-sectional study included 27 patients with PCI and 16 patients who had undergone CABG admitted to the CR program. The Beck Depression Inventory (BDI) was used to determine the severity of depression symptoms, and the Situational and Trait Anxiety Inventory (STAI I-II) were used. Results: After CR, the BDI, STAI-1, and STAI-2 significantly decreased in both the PCI (P<0.001, P=0.002, and P=0.006, respectively) and CABG groups (P<0.001, P=0.001, and P=0.015, respectively) compared to before CR. The change in BDI was higher in the CABG group (P=0.033), while there were no significant differences between the changes in STAI-1 and STAI-2 scores (P=0.378 and P=0.361). Conclusion: The results of this study demonstrate the CR benefits for depression and anxiety in patients undergoing CABG and PCI. On the other hand, CABG patients show relatively more benefit in terms of depressive symptoms. Prospective and controlled studies with larger sample sizes are needed to support our findings.

Özet

Amaç: Bu çalışmada, Kardiyak Rehabilitasyon (CR) programının Perkütan Koroner Girişim (PKG) ve Koroner Arter Bypass Greftleme (KABG) uygulanan hastalarda anksiyete ve depresyon üzerindeki etkilerini ve anksiyete ve depresyon belirtilerinin değişimini araştırmayı amaçladık. Yöntemler: Bu retrospektif takip çalışmasında, PKG uygulanan 27 hasta ve KABG uygulanan 16 hasta CR programına kabul edildi. Hastalarda, depresyon belirtilerinin şiddetini belirlemek için Beck Depresyon Envanteri (BDE) kullanıldı; Durumsal ve Sürekli Kaygı Envanteri (STAI I-II) kullanıldı. Bulgular: Hem PKG hem de KABG hastalarında BDE ve STAI I-II skorları arasında istatistiksel anlamlılık bulundu (PKG için sırasıyla <0.001, 0.002 ve 0.006, KABG için <0.001, 0.001 ve 0.015). İki hasta grubunda BDE skorları ile STAI I-II skorları arasında istatistiksel olarak anlamlı fark vardı (p = 0,033). Ancak, STAI I ve STAI II skorları arasında istatistiksel olarak anlamlı bir fark yoktu (p = 0,378 ve 0,361). Sonuç: Bu çalışmanın sonuçları, KABG ve PKG uygulanan hastalarda CR'nin depresyon ve anksiyete belirtilerinde faydalı olduğunu göstermektedir. Öte yandan, KABG hastaları depresif belirtiler açısından görece daha fazla fayda görmektedir. Bulgularımızı desteklemek için daha büyük örneklem büyüklüğüne sahip ileriye dönük ve kontrollü çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Gündoğmuş, P. D., Gündoğmuş, İ. (2021). The effect of cardiac rehabilitation on anxiety and depression in percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) patients. Journal of Surgery and Medicine, Cilt: 5 Sayı: 9, 867–870. https://doi.org/10.28982/josam.852415

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic medicine. 2004;66:802-13.
  2. Kubzansky LD, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease? Journal of psychosomatic research. 2000;48:323-37.
  3. Taggart DP. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. The Annals of thoracic surgery. 2006;82:1966-75.
  4. Soran O, Manchanda A, Schueler S. Percutaneous coronary intervention versus coronary artery bypass surgery in multivessel disease: a current perspective. Interactive cardiovascular and thoracic surgery. 2009;8:666-71.
  5. Sullivan MD, LaCroix AZ, Spertus JA, Hecht J. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. The American journal of cardiology. 2000;86:1135-8, A6, A9.
  6. Frasure-Smith N, Lespérance F. Reflections on depression as a cardiac risk factor. Psychosomatic medicine. 2005;67:S19-S25.
  7. Gündüz A, Gündoğmuş İ. Üniversite öğrencilerinde çocukluk çağı olumsuz yaşantıları ile otomatik düşünceler, ara inançlar, uyumsuz şemalar, anksiyete ve depresif belirti şiddeti ve yaşam kalitesi arasındaki ilişki. Klinik Psikiyatri Dergisi. 2019;22:424-35.
  8. Van Dijk MR, Utens EM, Dulfer K, Al-Qezweny MN, van Geuns R-J, Daemen J, van Domburg RT. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up. European journal of preventive cardiology. 2016;23:552-8.
  9. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: A scientific statement from the american heart association exercise, cardiac rehabilitation, and prevention committee, the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the american association of cardiovascular and pulmonary rehabilitation. Circulation. 2007;115:2675-82.
  10. Jolliffe J, Rees K, Taylor R, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2001:CD001800.
  11. Kulcu D, Kurtais Y, Tur B, Gulec S, Seckin B. The effect of cardiac rehabilitation on quality of life, anxiety and depression in patients with congestive heart failure. A randomized controlled trial, short-term results. Europa Medicophysica. 2007;43:489-97.
  12. Solak Ö, Yaman F, Ulaşlı M, Eroğlu S, Akçi Ö, Özkeçeci G, Toktaş H, Dündar Ü. Improvement in quality of life, functional capacity, and depression level after cardiac rehabilitation. Turk J Phys Med Rehab. 2015;61:130-5.
  13. Demir Gündoğmuş P, Topçu Özcan B, Hayıroğlu M, Gündoğmuş İ, Ölçü EB, Uzun M, Orhan AL. The effect of age on outcomes in a cardiac rehabilitation center from Turkey. Archives of the Turkish Society of Cardiology. 2020;48:270-7.
  14. Sharif F, Shoul A, Janati M, Kojuri J, Zare N. The effect of cardiac rehabilitation on anxiety and depression in patients undergoing cardiac bypass graft surgery in Iran. BMC cardiovascular disorders. 2012;12:40.
  15. Hisli N. Beck depresyon envanterinin universite ogrencileri icin gecerliligi, guvenilirligi.(A reliability and validity study of Beck Depression Inventory in a university student sample). J Psychol. 1989;7:3-13.
  16. Öner N, Le Compte A. Durumluk Sürekli Anksiyete Envanteri el kitabı. İstanbul: Boğaziçi Üniversitesi Yayınları. 1985.
  17. Moradian ST, Msc FF. Comparison of hospital anxiety and depression among patients with coronary artery disease based on proposed treatment. Iranian journal of critical care nursing. 2011;4:97-102.
  18. Glazer KM, Emery CF, Frid DJ, Banyasz RE. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. 2002;22:40-6.
  19. Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosomatic medicine. 2013;75:335-49.
  20. Gundogmus PD. The effect of gender on anxiety and depressive symptoms in Turkish cardiac rehabilitation patients. Annals of Medical Research. 2019;26:670-5.
  21. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. Journal of psychosomatic research. 2002;53:897-902.
  22. Kulik JA, Mahler HI. Social support and recovery from surgery. Health Psychology. 1989;8:221.
  23. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus–pituitary–adrenal axis. Biological psychology. 2001;57:141-52.
  24. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosomatic medicine. 2004;66:305-15.
  25. Gundogmus İ, Algul A, Karagöz A, Kıyançiçek M. PDW and RDW are new parameters for bipolar episodes and unipolar depression. Psychiatry and Clinical Psychopharmacology. 2018;29:1-7.